January 5, 2012 |
The little boy was 2 years old, and his name was River. On the night of July 22, 2010, he had a fever. Mothers and fathers worry about little boys with fevers, so Katy Moore gave her son Very Berry Strawberry Children's Tylenol. Within 30 minutes, he was spitting up blood. By the next day, he was dead from liver failure. In a lawsuit filed in Philadelphia Common Pleas Court, Daniel and Katy Moore of Ellensburg, Wash., southeast of Seattle, blame Tylenol's manufacturer, Johnson & Johnson Inc., and its McNeil Consumer Healthcare subsidiary, which has a plant and headquarters in Fort Washington, Montgomery County.
February 16, 1986 |
Drug manufacturers may be forced to change the way they package some of the nation's most popular over-the-counter drugs in the wake of the most recent Tylenol poisoning. The easy-to-swallow gelatin capsule - used by millions who prefer it over the round, hard, tablet form of medication - has been linked in the public's consciousness to tragedy. And some industry officials and financial analysts say that link may lead to the capsule's eventual disappearance from consumer markets.
May 21, 2010 |
Robert Lincoln McNeil Jr., 94, the Philadelphia chemist who introduced the world to the best-selling painkiller Tylenol and later sold his family business to pharmaceutical giant Johnson & Johnson, died Thursday of heart failure at his Wyndmoor home. A grandson of Robert McNeil, who founded the company that became McNeil Laboratories in a Kensington drugstore in 1879, Mr. McNeil also was a major patron of many cultural and educational institutions, including the Philadelphia Museum of Art, the Philadelphia Zoo, the University of Pennsylvania, the University of the Sciences, and Yale University.
May 2, 1986 |
McNeil Pharmaceutical Laboratories, the Spring House, Montgomery County, subsidiary of Johnson & Johnson, is warning physicians of an unexpected and puzzling reaction to its new pain-alleviating drug Suprol, the Food and Drug Administration said yesterday. The reaction includes pain and reduced kidney function. The FDA said it has received 16 reports of patients experiencing flank and back pain accompanied by evidence of decreased kidney function shortly after taking Suprol.
July 18, 2012 |
After Johnson & Johnson reported lower overall sales and profit for the second quarter Tuesday, in part because of continuing problems at its McNeil Consumer Healthcare facility in Fort Washington, new chief executive officer Alex Gorsky was asked why he was not considering selling pieces of the health-care giant. Goldman Sachs pharmaceutical analyst Jami Rubin wrote in May that J&J should follow the example of Pfizer Inc. and Abbott Laboratories Inc. and separate its three divisions — consumer products, pharmaceuticals, and devices — because it couldn't manage them all in a way to get full value.
May 11, 1989 |
PAINKILLER HAZARDS. Regular, long-term use of the painkiller acetaminophen increases the risk of developing kidney disease. That's according to a new study reported in the New England Journal of Medicine. Acetaminophen is the main ingredient in Tylenol and other medications. But Kidney Foundation president Saulo Klahr, who read the study, said you'd have to take roughly 325 milligrams (one regular-strength tablet) a day of Tylenol for about 20 years to accumulate the kind of dosage that might lead to chronic kidney disease.
August 7, 1988 |
McNeil Consumer Products Inc., a Fort Washington-based pharmaceutical company that manufactures Tylenol and Co-Tylenol, has withdrawn a request to land helicopters at its plant. The withdrawal was announced to the Whitemarsh Township Zoning Hearing Board at its meeting Wednesday night. McNeil's withdrawal ends nearly 10 months of wrangling with Whitemarsh. The township joined several area residents in opposing the landings and sent township solicitor Ross Weiss to the Planning Commission and Zoning Hearing Board meetings involving the request.
March 25, 1986 |
A man claiming to have poisoned three popular non-prescription drugs telephoned WCAU-TV (Channel 10) here yesterday and boasted that a $900,000 reward was "not enough" to capture him. The call came after a national association of drug manufacturers, angered by the recent Tylenol and Contac poisonings, yesterday offered a $700,000 reward for information leading to the arrest of the drug tamperer or tamperers. The Proprietary Association, which represents 83 makers of over-the-counter medicines, said it would add the reward to the $200,000 already offered by Johnson & Johnson in the Tylenol poisonings.
May 19, 2012 |
McNeil Consumer Healthcare, the beleaguered Fort Washington drug maker, recalled more products on Thursday. This time, McNeil recalled one lot of Imodium Multi-Symptom Relief, an over-the-counter medicine for diarrhea, gas, bloating and cramps. A company spokeswoman said the 53,892 packages in that lot are likely still with wholesalers, so the recall is directed mainly toward them. Some of the packages might be torn. She said McNeil has no safety concerns about the products in torn packages, but having been exposed to air, the medicine might not provide the intended benefits.